Identification of the second heparin-binding domain in human complement factor H1

Journal of Immunology

Volumn 160, Issue 7, 1998, Pages 3342-3348

  Blackmore, Timothy K ^a   Hellwage, Jens ^b   Sadlon, Tania A ^a   Higgs, Naomi ^a   Zipfel, Peter F ^b   Ward, Helena M ^a   Gordon, David L ^a  

^a FLINDERS MEDICAL CENTRE   (Australia)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AFFINITY CHROMATOGRAPHY; AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; BINDING SITE; CHO CELL; COMPLEMENT ALTERNATIVE PATHWAY; DELETION MUTANT; GENETIC RECOMBINATION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; SEQUENCE HOMOLOGY;

APOLIPOPROTEINS; BINDING SITES; BLOOD PROTEINS; COMPLEMENT FACTOR H; CONSENSUS SEQUENCE; HEPARIN; HUMANS; PROTEIN STRUCTURE, TERTIARY; RECOMBINANT PROTEINS; REPETITIVE SEQUENCES, NUCLEIC ACID; SEQUENCE DELETION;

EID: 0032055196     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Hourcade, D., V. M. Holers, and J. P. Atkinson. 1989. The regulators of complement activation (RCA) gene cluster. Adv. Immunol. 45:381.
2. Liszewski, M. K., T. C. Farries, D. M. Lublin, I. A. Rooney, and J. P. Atkinson. 1996. Control of the complement system. Adv. Immunol. 61:201.
3. Barlow, P. N., and I. D. Campbell. 1994. Strategy for studying modular proteins: application to complement modules. Methods Enzymol. 239:465.
4. Barlow, P. N., A. Steinkasserer, D. G. Norman, B. Kieffer, A. P. Wiles, R. B. Sim, and I. D. Campbell. 1993. Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol. 232:268.
5. Whaley, K., and S. Ruddy. 1976. Modulation of the alternative complement pathway by β1H globulin. J. Exp. Med. 144:1147.
6. Weiler, J. M., M. R. Daha, K. F. Austen, and D. T. Fearon. 1976. Control of the amplification convertase of complement by the plasma protein β1H. Proc. Natl. Acad. Sci. USA 73:3268.
7. Pangburn, M. K., R. D. Schreiber, and H. J. Müller-Eberhard. 1977. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein β1H for cleavage of C3b and C4b in solution. J. Exp. Med. 146:257.
8. Gordon, D. L., R. M. Kaufman, T. K. Blackmore, J. Kwong, and D. M. Lublin. 1995. Identification of complement regulatory domains in human factor H. J. Immunol. 155:348.
9. Kühn, S., C. Skerka, and P. F. Zipfel. 1995. Mapping of the complement regulatory domains in the human factor H-like protein 1 and in factor H. J. Immunol. 155:5663.
10. Kühn, S., and P. F. Zipfel. 1996. Mapping of the domains required for decay acceleration activity of the human factor H-like protein 1 and factor H. Eur. J. Immunol. 26:2383.
11. Sharma, A. K., and M. K. Pangburn. 1996. Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl. Acad. Sci. USA 93:10996.
12. Pangburn, M. K., D. C. Morrison, R. D. Schreiber, and H. J. Müller-Eberhard. 1980. Activation of the alternative complement pathway: recognition of surface structures on activators by bound C3b. J. Immunol. 124:977.
13. Kazatchkine, M. D., D. T. Fearon, and K. F. Austen. 1979. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and β1H for cell-bound C3b. J. Immunol. 122:75.
14. Fearon, D. T. 1978. Regulation by membrane sialic acid of β1H-dependent decay-dissociation of amplification C3 convertase of the alternative complement pathway. Proc. Natl. Acad. Sci. USA 75:1971.
15. Pangburn, M. K., and H. J. Müller-Eberhard. 1978. Complement C3 convertase: cell surface restriction of β1H control and generation of restriction on neuraminidase-treated cells. Proc. Natl. Acad. Sci. USA 75:2416.
16. Horstmann, R. D., M. K. Pangburn, and H. J. Müller-Eberhard. 1985. Species specificity of recognition by the alternative pathway of complement. J. Immunol. 134:1101.
17. Pangburn, M. K., M. A. L. Atkinson, and S. Meri. 1991. Localization of the heparin-binding site on complement factor H. J. Biol. Chem. 266:16847.
18. Blackmore, T. K., T. A. Sadlon, H. M. Ward, D. M. Lublin, and D. L. Gordon. 1996. Identification of a heparin binding domain in the seventh short consensus repeat of complement factor H. J. Immunol. 157:5422.
19. Vik, D. P., P. Muñoz-Cánoves, H. Kozono, L. G. Martin, B. F. Tack, and D. D. Chaplin. 1990. Identification and sequence analysis of four complement factor H-related transcripts in mouse liver. J. Biol. Chem. 265:3193.
20. Zipfel, P. F., and C. Skerka. 1994. Complement factor H and related proteins: an expanding family of complement-regulatory proteins? Immunol. Today 15:121.
21. Skerka, C., R. D. Horstmann, and P. F. Zipfel. 1991. Molecular cloning of a human serum protein structurally related to complement factor H. J. Biol. Chem. 266:12015.
22. Estaller, C., V. Koistinen, W. Schwaeble, M. P. Dierich, and E. H. Weiss. 1991. Cloning of the 1.4-kb mRNA species of human complement factor H reveals a novel member of the short consensus repeat family related to the carboxy terminal of the classical 150-kDa molecule. J. Immunol. 146:3190.
23. Skerka, C., C. Timmann, R. D. Horstmann, and P. F. Zipfel. 1992. Two additional human serum proteins structurally related to complement factor H. Evidence for a family of factor H-related genes. J. Immunol. 148:3313.
24. Skerka, C., J. Hellwage, W. Weber, A. Tilkorn, F. Buck, T. Marti, E. Kampen, U. Beisiegel, and P. F. Zipfel. 1997. The human factor H-related protein 4 (FHR-4) - a novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins. J. Biol. Chem. 272:5627.
25. Park, C. T., and S. D. Wright. 1996. Plasma lipopolysaccharide-binding protein is found associated with a particle containing apolipoprotein a-I, phospholipid, and factor H-related proteins. J. Biol. Chem. 271:18054.
26. Kühn, S., and P. F. Zipfel. 1995. The baculovirus expression vector pBSV-8His directs secretion of histidine-tagged proteins. Gene 162:225.
27. Zammit, A., D. S. Pepper, and J. Dawes. 1993. Interaction of immobilised unfractionated and LMW heparins with proteins in whole human plasma. Thromb. Haemost. 70:951.
28. Vik, D. P., P. Muñoz-Cánoves, D. D. Chaplin, and B. F. Tack. 1989. Factor H. Curr. Top. Microbiol. Immunol. 153:147.
29. Sharma, A. K., and M. K. Pangburn. 1997. Localization by site-directed mutagenesis of the site in human complement factor h that binds to Streptococcus pyogenes M protein. Infect. Immun. 65:484.
30. Coyne, K. E., S. E. Hall, S. Thompson, M. A. Arce, T. Kinoshita, T. Fujita, D. J. Anstee, W. Rosse, and D. M. Lublin. 1992. Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J. Immunol. 149:2906.
31. 2 chimeric complement inhibitor. J. Exp. Med. 174:1451.
32. Kalli, K. R., J. M. Ahearn, and D. T. Fearon. 1991. Interaction of iC3b with recombinant isotypic and chimeric forms of CR2. J. Immunol. 147:590.
33. Barlow, P. N., D. G. Norman, A. Steinkasserer, T. J. Horne, J. Pearce, P. C. Driscoll, R. B. Sim, and I. D. Campbell. 1992. Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry 31:3626.
34. Norman, D. G., P. N. Barlow, M. Baron, A. J. Day, R. B. Sim and I. D. Campbell. 1991. Three-dimensional structure of a complement control protein module in solution. J. Mol. Biol. 219:717.
35. Barlow, P. N., M. Baron, D. G. Norman, A. J. Day, A. C. Willis, R. B. Sim, and I. D. Campbell. 1991. Secondary structure of a complement control protein module by two-dimensional 1H NMR. Biochemistry 30:997.
36. Soames, C. J., A. J. Day, and R. B. Sim. 1996. Prediction from sequence comparisons of residues of factor H involved in the interaction with complement component C3b. Biochem. J. 315:523.
37. Ripoche, J., A. J. Day, T. J. R. Harris, and R. B. Sim. 1988. The complete amino acid sequence of human complement factor H. Biochem. J. 249:593.
38. Faham, S., R. E. Hileman, J. R. Fromm, R. J. Linhardt, and D. C. Rees. 1996. Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116.
39. Edwards, M. S., D. L. Kasper, H. J. Jennings, C. J. Baker, and A. Nicholson-Weller. 1982. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. J. Immunol. 128: 1278.
40. Marques, M. B., D. L. Kasper, M. K. Pangburn, and M. R. Wessels. 1992. Prevention of C3 deposition by capsular polysaccharide is a virulence mechanism of type III group B streptococci. Infect. Immun. 60:3986.
41. Jarvis, G. A. 1994. Analysis of C3 deposition and degradation on Neisseria meningitidis and Neisseria gonorrhoeae. Infect. Immun. 62:1755.
42. Alcorn, T. M., and M. S. Cohen. 1994. Gonococcal pathogenesis: adaptation and immune evasion in the human host. Curr. Opin. Infect. Dis. 7:310.
43. Mandrell, R. E., A. J. Lesse, J. V. Sugai, M. Shero, J. Griffis, J. A. Cole, N. J. Parsons, H. Smith, S. A. Morse, and M. A. Apicella. 1990. In vitro and vivo modification of Neisseria gonorrhoeae lipooligosaccharide epitope structure by sialylation. J. Exp. Med. 171:1649.
44. Smith, H., N. J. Parsons, and J. A. Cole. 1995. Sialylation of neisserial lipopolysaccharide: a major influence on pathogenicity. Microb. Pathog. 19:365.
45. Stevens, P., S. N.-Y. Huang, W. D. Welch, and L. S. Young. 1978. Restricted complement activation by Escherichia coli with the K-1 capsular serotype: a possible role in pathogenicity. J. Immunol. 121:2174.
46. Ezzell, J. L., and C. J. Parker. 1992. Cell-surface regulation of the human alternative pathway of complement: sheep but not rabbit erythrocytes express factor I-dependent cofactor activity. Scand. J. Immunol. 36:79.